Evidence map›Paper›PMID 30232087›Full record

ArticleBlood advances2018

Phenotype description and response to thrombopoietin receptor agonist in

Sarah K Westbury, Kate Downes, Claire Burney, Maria L Lozano, Samya G Obaji, Cheng Hock Toh, Teresa Sevivas, Neil V Morgan, Wendy N Erber, Carly Kempster and 10 more

Abstract readCase Reports
In one paragraph

Article in Blood advances, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed.

  1. Trial
  2. Article
  3. Review
  4. Article
  5. Review
  6. Review
  7. Review
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Inherited Platelet Disorders: An Updated Overview.International journal of molecular sciences · 2021
    Review
  14. Role of Thrombopoietin Receptor Agonists in Inherited Thrombocytopenia.International journal of molecular sciences · 2021
    Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Sarah K WestburySchool of Cellular and Molecular Medicine and.ORCID 0000-0002-0950-8148
Kate DownesNIHR BioResource-Rare Diseases, Cambridge University Hospitals, Cambridge, United Kingdom.
Claire BurneyUniversity Hospitals Bristol NHS Foundation Trust, Bristol, United Kingdom.
Maria L LozanoServicio de Hematología y Oncología Médica, Hospital Universitario Morales Meseguer, Centro Regional de Hemodonación, Universidad de Murcia, IMIB-Arrixaca, CIBERER-U765, Murcia, Spain.
Samya G ObajiDepartment of Haematology, School of Medicine, Cardiff University, Cardiff, United Kingdom.
Cheng Hock TohRoald Dahl Haemostasis and Thrombosis Centre, Royal Liverpool University Hospital, Liverpool, United Kingdom.
Teresa SevivasServiço de Sangue, Medicina Transfusional e Imunohemoterapia do Centro Hospitalar e Universitário de Coimbra, Coimbra, Portugal.
Neil V MorganInstitute of Cardiovascular Sciences, College of Medical and Dental Sciences, University of Birmingham, Birmingham, United Kingdom.
Wendy N ErberNIHR BioResource-Rare Diseases, Cambridge University Hospitals, Cambridge, United Kingdom.
Carly KempsterDepartment of Haematology, University of Cambridge, Cambridge Biomedical Campus, Cambridge, United Kingdom.
Samantha F MooreSchool of Physiology, Pharmacology and Neuroscience, University of Bristol, Bristol, United Kingdom.
Chantal ThysDepartment of Cardiovascular Sciences, Center for Molecular and Vascular Biology, University of Leuven, Leuven, Belgium.
Sofia PapadiaNIHR BioResource-Rare Diseases, Cambridge University Hospitals, Cambridge, United Kingdom.ORCID 0000-0002-9222-3812
Willem H OuwehandNIHR BioResource-Rare Diseases, Cambridge University Hospitals, Cambridge, United Kingdom.
NIHR BioResource–Rare Diseases
Michael A LaffanNIHR BioResource-Rare Diseases, Cambridge University Hospitals, Cambridge, United Kingdom.
Keith GomezNIHR BioResource-Rare Diseases, Cambridge University Hospitals, Cambridge, United Kingdom.ORCID 0000-0002-8934-0700
Kathleen FresonNIHR BioResource-Rare Diseases, Cambridge University Hospitals, Cambridge, United Kingdom.
Jose RiveraServicio de Hematología y Oncología Médica, Hospital Universitario Morales Meseguer, Centro Regional de Hemodonación, Universidad de Murcia, IMIB-Arrixaca, CIBERER-U765, Murcia, Spain.
Andrew D MumfordSchool of Cellular and Molecular Medicine and.

Funding

British Heart Foundation FS/16/20/32005British Heart Foundation PG/13/36/30275British Heart Foundation PG/16/3/31833Medical Research Council MR/J011711/1Medical Research Council MR/K023489/1Wellcome Trust
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Genetic Association StudiesPhenotypeAdaptor Proteins, Signal TransducingAdolescentAdultAgedBiomarkersChildChild, PreschoolFemaleForminsHumansMaleMiddle AgedPedigreeReceptors, ThrombopoietinAdaptor Proteins, Signal TransducingBiomarkersDIAPH1 protein, humanForminsReceptors, Thrombopoietin

Identifiers

PMID30232087
PMCPMC6156883

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.